12/27
01:18 pm
sbra
Sabra (SBRA) Upgraded to Buy: Here's Why [Yahoo! Finance]
Neutral
Report
Sabra (SBRA) Upgraded to Buy: Here's Why [Yahoo! Finance]
11/30
03:38 am
sbra
Sabra Health Care REIT: A Promising Value Play In Healthcare Real Estate [Seeking Alpha]
Low
Report
Sabra Health Care REIT: A Promising Value Play In Healthcare Real Estate [Seeking Alpha]
11/6
05:06 pm
sbra
Sabra Health Care REIT, Inc. to Attend Nareit's REITworld 2024 Annual Conference [Yahoo! Finance]
Medium
Report
Sabra Health Care REIT, Inc. to Attend Nareit's REITworld 2024 Annual Conference [Yahoo! Finance]
11/6
04:05 pm
sbra
Sabra Health Care REIT, Inc. to Attend Nareit’s REITworld 2024 Annual Conference
Medium
Report
Sabra Health Care REIT, Inc. to Attend Nareit’s REITworld 2024 Annual Conference
11/1
01:53 pm
sbra
Sabra Health Care REIT, Inc. 2024 Q3 - Results - Earnings Call Presentation [Seeking Alpha]
Low
Report
Sabra Health Care REIT, Inc. 2024 Q3 - Results - Earnings Call Presentation [Seeking Alpha]
10/31
08:35 pm
sbra
Sabra (SBRA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
Medium
Report
Sabra (SBRA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
10/31
04:05 pm
sbra
Sabra Reports Third Quarter 2024 Results; Updates 2024 Guidance
Medium
Report
Sabra Reports Third Quarter 2024 Results; Updates 2024 Guidance
10/21
04:05 pm
sbra
Moody’s Upgrades Sabra Health Care REIT, Inc.’s Outlook to Positive, Affirms Credit Rating
Low
Report
Moody’s Upgrades Sabra Health Care REIT, Inc.’s Outlook to Positive, Affirms Credit Rating
10/17
04:05 pm
sbra
Sabra Health Care REIT, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call
Low
Report
Sabra Health Care REIT, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call
10/11
10:35 am
sbra
Sabra Health Care REIT, Inc. (NASDAQ: SBRA) had its price target raised by analysts at Scotiabank from $17.00 to $18.00. They now have a "sector perform" rating on the stock.
Low
Report
Sabra Health Care REIT, Inc. (NASDAQ: SBRA) had its price target raised by analysts at Scotiabank from $17.00 to $18.00. They now have a "sector perform" rating on the stock.